BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30303146)

  • 21. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
    McCluggage WG; Sumathi VP; McBride HA; Patterson A
    Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic utility of human papillomavirus-testing in combination with immunohistochemistry in advanced gynaecologic pelvic tumours: a new diagnostic approach.
    Park TW; Zivanovic O; Theuerkauf I; Dürkop B; Hernando JJ; Simon M; Büttner R; Kuhn W
    Int J Oncol; 2004 Apr; 24(4):829-36. PubMed ID: 15010819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of the Uterine Cervix.
    Dietl AK; Beckmann MW; Stuebs FA; Gass P; Emons J; Hartmann A; Erber R
    Int J Gynecol Pathol; 2024 Jul; 43(4):397-404. PubMed ID: 38293999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.
    Giordano G; D'Adda T; Gnetti L; Merisio C; Gabrielli M; Melpignano M
    Int J Gynecol Pathol; 2007 Apr; 26(2):199-204. PubMed ID: 17413990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge.
    Korach J; Machtinger R; Perri T; Vicus D; Segal J; Fridman E; Ben-Baruch G
    Acta Obstet Gynecol Scand; 2009; 88(3):355-8. PubMed ID: 19172445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of high-risk human papillomavirus DNA and immunohistochemical expressions of p16, vimentin, ER, and PR in primary endocervical and endometrial adenocarcinomas.
    Xiong Y; Xiong YY; Xu ZG
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):517-521. PubMed ID: 29894077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor does not improve the performance and test effectiveness of the conventional 3-marker panel, consisting of estrogen receptor, vimentin and carcinoembryonic antigen in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Liao CL; Lee MY; Tyan YS; Kok LF; Wu TS; Koo CL; Wang PH; Chao KC; Han CP
    J Transl Med; 2009 May; 7():37. PubMed ID: 19476621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Villoglandular adenocarcinoma of cervix--a tumour with bland cytological features: report of a case missed on cytology.
    Jayaram G; Razak A
    Malays J Pathol; 2003 Dec; 25(2):139-43. PubMed ID: 16196371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
    Lu X; Toki T; Konishi I; Nikaido T; Fujii S
    Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint.
    Kamoi S; AlJuboury MI; Akin MR; Silverberg SG
    Int J Gynecol Pathol; 2002 Jul; 21(3):217-23. PubMed ID: 12068166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: cytomorphologic observation of five cases.
    Khunamornpong S; Siriaunkgul S; Suprasert P
    Diagn Cytopathol; 2002 Jan; 26(1):10-4. PubMed ID: 11782079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.